Mink Therapeutics, INC. (INKT) — SC 13D Filings
All SC 13D filings from Mink Therapeutics, INC.. Browse 1 Activist Stake Filing reports with AI-powered summaries and risk analysis.
SC 13D Filings (1)
-
Insider Garo Armen Files SC 13D for MiNK Therapeutics
— Feb 14, 2024 Risk: low
Garo H. Armen filed an SC 13D on February 14, 2024, concerning MiNK Therapeutics, Inc. common stock, which has a par value of $0.00001 per share and CUSIP 60369
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX